The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 to recommend the 2023-2024 monovalent, XBB containing COVID-19 vaccines as authorized under the FDA’s Emergency Use Authorization (EUA) or approved by Biologics License Application (BLA) for all persons ages 6 months and older.  Yesterday, the FDA approved the updated boosters.   Presentations:  A total of 13 presentations were included in the meeting.  All are available… (Joyce, September 12, 2023) #COVID-19, #Health Equity, #Prevention, #Primary Care